Comprehensive patent counsel for publicly traded pharmaceutical company developing small molecule therapeutics for treatment of cystic fibrosis and other premature stop codon-related diseases.  Representation includes patent procurement, management of licensed and original patent portfolios, and due diligence relating to licensing and financing.